
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc Interest Expense 2011-2026 | NVCN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 133 K | - | - | - | 2.54 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 133 K | 2.54 K | 67.8 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.27 | -1.36 % | $ 5.85 K | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 7.82 | 4.13 % | $ 561 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 9.4 | -2.49 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.99 | -2.68 % | $ 149 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 43.41 | -5.2 % | $ 1.35 B | ||
|
Electromed
ELMD
|
78 K | $ 23.98 | -0.5 % | $ 203 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 29.83 | -2.68 % | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.17 | -3.35 % | $ 110 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.5 | -0.32 % | $ 121 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.53 | -4.57 % | $ 54.5 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 182.64 | -3.38 % | $ 13.7 B | ||
|
Inari Medical
NARI
|
294 K | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.68 | -4.42 % | $ 779 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
548 M | $ 113.61 | -0.45 % | $ 198 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 73.85 | -3.11 % | $ 109 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.98 | -6.6 % | $ 1.2 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 13.02 | -3.34 % | $ 1.95 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 85.28 | -2.18 % | $ 49.9 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 104.29 | 0.53 % | $ 1.32 B |